Search
Boston Scientific's New OPAL HDx™ 3D Mapping System Officially Approved in China
1 day ago /
Read about 0 minute
Author：小编
On March 6, 2026, Boston Scientific Corporation announced that its new OPAL HDx™ 3D Electroanatomical Mapping System for cardiac electrophysiology has officially received approval from the National Medical Products Administration. The system is equipped with the FARAVIEW™ software module and can be used in conjunction with the FARAWAVE™ NAV single-use magnetic-enabled cardiac pulse field ablation catheter, which features new magnetic localization capabilities, to achieve 3D cardiac mapping functionality.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
